Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBOAT4 | Q96T53 | 3/20 | 0.62 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.49 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.44 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.44 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 6/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 6/20 | 0.44 |
| ▸ | SHBG | P04278 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21176005 | 1.00 | MBOAT4 (0.62) | MBOAT4CYP19A1CDK5CDK5R1NR1I3 | |
| SCHEMBL1781352 | 1.00 | MBOAT4 (0.62) | MBOAT4CYP19A1CDK5CDK5R1NR1I3 | |
| SCHEMBL29688566 | 1.00 | MBOAT4 (0.62) | MBOAT4CYP19A1CDK5CDK5R1NR1I3 | |
| SCHEMBL4802159 | 1.00 | MBOAT4 (0.62) | MBOAT4CYP19A1CDK5CDK5R1NR1I3 | |
| SCHEMBL3268576 | 0.81 | MBOAT4 (0.53) | MBOAT4CYP19A1CDK5CDK5R1NR1I3 | |
| SCHEMBL1788661 | 0.80 | MBOAT4 (0.46) | MBOAT4CYP19A1GRIN1GRIN2BSHBG | |
| SCHEMBL2186022 | 0.79 | CYP19A1 (0.55) | CYP19A1SHBG | |
| SCHEMBL1287860 | 0.79 | CYP19A1 (0.55) | CYP19A1SHBG | |
| SCHEMBL1287861 | 0.79 | CYP19A1 (0.55) | CYP19A1SHBG | |
| SCHEMBL9512557 | 0.79 | CYP19A1 (0.55) | CYP19A1SHBG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1078 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713674-A1 | SENSOR DEVICE | Université de Mons (BE) | 2026-03-25 | — | — | EP | claimed |
| US-12548641-B2 | Methods and techniques for processing responses of an olfactory test | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2026-02-10 | — | — | US | claimed |
| US-12449390-B2 | Analyte detection system | UNIVERSITY OF THE WEST OF ENGLAND, BRISTOL (GB) | 2025-10-21 | — | — | US | claimed |
| EP-3462875-B1 | DEVICE FOR ATTRACTING A RODENT | GRIES GERHARD J (CA) | 2025-05-07 | — | — | EP | claimed |
| CN-119816291-A | Agent for promoting formation of horny layer | 株式会社资生堂 | 2025-04-11 | — | — | CN | claimed |
| EP-4531865-A1 | NON-SURGICAL PREVENTION OF BOAR TAINT AND AGGRESSIVE BEHAVIOR | Insigna Inc. (US) | 2025-04-09 | — | — | EP | claimed |
| CN-119595611-A | Method for rapidly detecting androgenic steroid based on surface enhanced Raman scattering technology and application thereof | 上海体育大学 | 2025-03-11 | — | — | CN | claimed |
| EP-4097460-B1 | ANALYTE DETECTION SYSTEM | UNIV OF THE WEST OF ENGLAND BRISTOL (GB) | 2025-01-08 | — | — | EP | claimed |
| WO-2024240671-A1 | SENSOR DEVICE | Université de Mons (BE) | 2024-11-28 | — | — | WO | claimed |
| CN-118986946-A | Boar odor composition, boar odor agent, and preparation methods and applications thereof | 宁波三生生物科技股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| EP-0649431-A1 | 17-AMINO SUBSTITUTED 4-AZASTEROID 5$g(a)-REDUCTASE INHIBITORS | MERCK & CO. INC. (US) | 1995-04-26 | — | — | EP | claimed |
| WO-1993023038-A1 | 17-AMINO SUBSTITUTED 4-AZASTEROID 5α-REDUCTASE INHIBITORS | MERCK & CO., INC. (US) | 1993-11-25 | — | — | WO | claimed |
| EP-0553054-A2 | A process for the examination of individual items for the contents of a fat-soluble compound | Slagteriernes Forskningsinstitut (DK) | 1993-07-28 | — | — | EP | claimed |
| EP-0209590-A1 | THE USE OF MALE ESSENCE, INCLUDING ANDROSTENOL AND DEHYDROEPIANDROSTERONE SULFATE TO TREAT LUTEAL PHASE DEFECTS AND FAILURE TO OVULATE IN HUMAN FEMALES | MONELL CHEMICAL SENSES CENTER (US) | 1987-01-28 | — | — | EP | claimed |
| WO-1986004236-A1 | THE USE OF MALE ESSENCE, INCLUDING ANDROSTENOL AND DEHYDROEPIANDROSTERONE SULFATE TO TREAT LUTEAL PHASE DEFECTS AND FAILURE TO OVULATE IN HUMAN FEMALES | MONELL CHEMICAL SENSES CENTER (US) | 1986-07-31 | — | — | WO | claimed |
| EP-0073026-B1 | 17,17-BIS(SUBSTITUTED THIO)-3-KETOANDROSTENES AND PHARMACEUTICAL COMPOSITIONS | E.R. Squibb & Sons, Inc. (US) | 1986-03-19 | — | — | EP | claimed |
| US-4384206-A | Process for detection of particular quality properties in individual articles of food | SLAGTERIERNES FORSKNINGSINSTITUT (DK) | 1983-05-17 | — | — | US | claimed |
| EP-0073026-A1 | 17,17-Bis(substituted thio)-3-ketoandrostenes and pharmaceutical compositions | E.R. Squibb & Sons, Inc. (US) | 1983-03-02 | — | — | EP | claimed |
| US-4361559-A | TOPICAL ADMINISTRATION FOR SKIN DISORDERS OF ASTHMA | E. R. SQUIBB & SONS, INC. (US) | 1982-11-30 | — | — | US | claimed |
| US-4267106-A | New process for the preparation 17β-hydroxy-3-oxo-17α-pregnene and pregnadiene-21-carboxylic acid γ-lactones | GIST BROCADES N.V. (NL) | 1981-05-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12548641-B2 | Methods and techniques for processing responses of an olfactory test | OR10J3, OR51E2, TAS2R16 | MBOAT4 993/4885CYP19A1 3448/4885CDK5 3916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.